Utilización de dos soportes para la inmovilización de la papaína

Papain was immobilized on activated carbon (AC) and on alumina (AL), with the aim of preparing low cost dietarysupplements, using whey as hydrolysed protein source. The quantifi cation of the non-adsorbed enzyme, using Lowry’smethod was used to determine the immobilization rate. The effect of the contact time and the temperature was tested,and 30 min at 250C was considered the best condition for immobilizing papain in both supports. AC showed muchhigher immobilization rates (from 95% to 99%) than AL (from 4% to 13%). The reusability of papain was evaluated bymeasuring the residual activity of the enzyme after it has been used for up to 20 times. The quantifi cation of exposurerate of phenylalanine by second derivative spectrophotometry was used to determine the enzyme activity. In this case, ALshowed better results than AC, since the activity of papain remained unchanged after 15 and 5 times, respectively.Con la intención de preparar suplementos dietéticos de bajo coste, se inmovilizó papaína en carbón activado (CA) yen alúmina, utilizando suero como fuente de proteínas hidrolizadas. Para determinar el índice de inmovilización secuantifi caron las enzimas no adsorbidas mediante el método de Lowry. Se analizó el efecto del tiempo de contactoy la temperatura, considerándose 30 min. a 25 ºC como la condición óptima para inmovilizar la papaína en ambossoportes. El CA presentó unos índices de inmovilización muy superiores (entre 95% y 99%) a los de la AL (entre4% y 13%). Para evaluar la capacidad de reutilización de la papaína se midió la actividad residual de la enzimadespués de haber sido utilizada hasta 20 veces. Para determinar la actividad de la enzima se cuantifi có el índice deexposición de la fenilalanina mediante espectrofotometría de derivada segunda. En este caso, la AL presentó mejoresresultados que el CA, ya que la actividad de la papaína seguía siendo la misma después de haber sido utilizada 15y 5 veces, respectivamente

Characterization of hNek6 Interactome Reveals an Important Role for Its Short N-Terminal Domain and Colocalization with Proteins at the Centrosome

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Physical protein protein interactions are fundamental to all biological processes and are organized in complex networks One branch of the kinome network is the evolutionarily conserved NIMA-related serine/threonine kinases (Neks) Most of the 11 mammalian Neks studied so far are related to cell cycle regulation and due to association with diverse human pathologies, Neks are promising chemotherapeutic targets Human Nek6 was associated to carcinogenesis but its interacting partners and signaling pathways remain elusive Here we introduce hNek6 as a highly connected member in the human kinase interactome In a more global context, we performed a broad data bank comparison based on degree distribution analysis and found that the human kinome is enriched in hubs Our networks include a broad set of novel hNek6 interactors as identified by our yeast two hybrid screens classified into 18 functional categories All of the tested interactions were confirmed and the majority of tested substrates were phosphorylated in vitro by hNek6 Notably, we found that hNek6 N-terminal is important to mediate the interactions with its partners Some novel interactors also colocalized with hNek6 and gamma-tubulin in human cells, pointing to a possible centrosomal interaction The interacting proteins link hNek6 to novel pathways, for example, Notch signaling and actin cytoskeleton regulation, or give new insights on how hNek6 may regulate previously proposed pathways such as cell cycle regulation, DNA repair response, and NF-kappa B signaling Our findings open new perspectives in the study of hNek6 role in cancer by analyzing its novel interactions in specific pathways in tumor cells which may provide important implications for drug design and cancer therapy91262986316Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Associacao Brasileira de Tecnologia de Luz Sincrotron (ABTLuS)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq

Human FEZ1 has characteristics of a natively unfolded protein and dimerizes in solution

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)The fasciculation and elongation protein Zeta 1 (FEZ1) is the mammalian orthologue of the Caenorhabditis elegans protein UNC-76, which is necessary for axon growth. Human FEZ1 interacts with Protein Kinase C (PKC) and several regulatory proteins involved in functions ranging from microtubule associated transport to transcriptional regulation. Theoretical prediction, circular dichroism, fluorescence spectroscopy, and limited proteolysis of recombinant FEZ1 suggest that it contains disordered regions, especially in its N-terminal region, and that it may belong to the group of natively unfolded proteins. Small angle X-ray scattering experiments indicated a mainly disordered conformation, proved that FEZ1 is a dimer of elongated shape and provided overall dimensional parameters for the protein. In vitro pull down experiments confirmed these results and demonstrated that dimerization involves the N-terminus. Ab-initio 3D low resolution models of the full-length conformation of the dimeric constructs 6xHis-FEZ1(1-392) and 6xHis-FEZ1(1-227) were obtained. Furthermore, we performed in vitro phosphorylation assays of FEZ1 with PKC. The phosphorylation occur-red mainly in its C-terminal region, and does not cause any significant conformational changes, but nonetheless inhibited its interaction with the FEZ1 interacting domain of the protein CLASP2 in vitro. The C terminus of FEZ1 has been reported to bind to several interacting proteins. This suggests that FEZ1 binding and transport function of interacting proteins may be subject to regulation by phosphorylation.741104121Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)CEPID [05/00235-1]Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)CEPID [05/00235-1

Involvement of forebrain imidazoline and alpha(2)-adrenergic receptors in the antidipsogenic response to moxonidine

We investigated the participation of central alpha(2)-adrenoceptors and imidazoline receptors in the inhibition of water deprivation-induced water intake in rats. The alpha(2)-adrenoceptor and imidazoline antagonist idazoxan (320 nmol), but not the alpha(2)-adrenoceptor antagonist yohimbine, abolished the antidipsogenic effect of moxonidine (alpha(2)-adrenoceptor and imidazoline agonist, 20 nmol) microinjected into the medial septal area. Yohimbine abolished the antidipsogenic effect of moxonidine intracerebroventricularly. Therefore, central moxonidine may inhibit water intake acting independently on both imidazoline receptors and alpha(2)-adrenoceptors at different forebrain sites

Central moxonidine on water and NaCl intake

In this study we investigated: (a) the effects of intracerebroventricular (i.c.v.) injections of moxonidine (an alpha(2)-adrenergic and imidazoline receptor agonist) on the ingestion of water and NaCl induced by 24 h of water deprivation; (b) the effects of i.c.v. injection of moxonidine on central angiotensin II (ANG II)- and carbachol-induced water intake; (c) the effects of the pre-treatment with i.c.v, idazoxan (an alpha(2)-adrenergic and imidazoline receptor antagonist) and RX 821002 (a selective alpha(2)-adrenergic antagonist) on the antidipsogenic action of central moxonidine. Male Holtzman rats had stainless steel cannulas implanted in the lateral cerebral ventricle. Intracerebroventricular injection of moxonidine (5 and 20 nmol/1 mu l) reduced the ingestion of 1.5% NaCl solution (4.1 +/- 1.1 and 2.9 +/- 2.5 ml/2 h, respectively vs. control = 7.4 +/- 2.1 ml/2 h) and water intake (2.0 +/- 0.6 and 0.3 +/- 0.2 ml/h, respectively vs. control = 13.0 +/- 1.4 ml/h) induced by water deprivation, Intracerebroventricular moxonidine (5 nmol/1 mu l) also reduced i.c.v. ANG Ii-induced water intake (2.8 +/- 0.9 vs. control = 7.9 +/- 1.7 ml/1 h) and i.c.v. moxonidine (10 and 20 nmol/1 mu l) reduced i.c.v. carbachol-induced water intake (4.3 +/- 1.7 and 2.1 +/- 0.9, respectively vs. control = 9.2 +/- 1.0 ml/1 h). The pre-treatment with i.c.v. idazoxan (40 to 320 nmol/1 mu l) abolished the inhibitory effect of i.c.v, moxonidine on carbachol-induced water intake. Intracerebroventricular idazoxan (320 nmol/1 mu l) partially reduced the inhibitory effect of moxonidine on water deprivation-induced water intake and produced only a tendency to reduce the antidipsogenic effect of moxonidine on ANG Ii-induced water intake. RX 821002 (80 and 160 nmol/1 mu l) completely abolished the antidipsogenic action of moxonidine on ANG Ii-induced water intake. The results show that central injections c: moxonidine strongly inhibit water and NaCl ingestion. They also suggest the involvement of central alpha(2)-adrenergic receptors in the antidipsogenic action of moxonidine. (C) 1999 Elsevier B.V

Mutant p53 Aggregates into Prion-like Amyloid Oligomers and Fibrils IMPLICATIONS FOR CANCER

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Over 50% of all human cancers lose p53 function. To evaluate the role of aggregation in cancer, we asked whether wild-type (WT) p53 and the hot-spot mutant R248Q could aggregate as amyloids under physiological conditions and whether the mutant could seed aggregation of the wild-type form. The central domains (p53C) of both constructs aggregated into a mixture of oligomers and fibrils. R248Q had a greater tendency to aggregate than WT p53. Full-length p53 aggregated into amyloid-like species that bound thioflavin T. The amyloid nature of the aggregates was demonstrated using x-ray diffraction, electron microscopy, FTIR, dynamic light scattering, cell viabilility assay, and anti-amyloid immunoassay. The x-ray diffraction pattern of the fibrillar aggregates was consistent with the typical conformation of cross beta-sheet amyloid fibers with reflexions of 4.7 angstrom and 10 angstrom. A seed of R248Q p53C amyloid oligomers and fibrils accelerated the aggregation of WTp 53C, a behavior typical of a prion. The R248Q mutant co-localized with amyloid-like species in a breast cancer sample, which further supported its prion-like effect. A tumor cell line containing mutant p53 also revealed massive aggregation of p53 in the nucleus. We conclude that aggregation of p53 into a mixture of oligomers and fibrils sequestrates the native protein into an inactive conformation that is typical of a prionoid. This prion-like behavior of oncogenic p53 mutants provides an explanation for the negative dominance effect and may serve as a potential target for cancer therapy.287332815228162Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB)Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (FAPERJ)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq